Privatizing the Human Genome?

Principals behind joint-venture proposal and public effort seek to define relationships A private effort to sequence the human genome four years ahead of the Human Genome Project's 2005 goal could either compete directly with the federal project or meld seamlessly with it. Before any relationship between the two efforts becomes formalized, scientists and federal officials involved with the Human Genome Project must determine whether the private approach will work, who will own the data, how qu

| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

The private effort, a joint venture between Perkin-Elmer Inc., a Norwalk, Conn., manufacturer of sequencing equipment, and J. Craig Venter , president and director of The Institute for Genomic Research (TIGR) in Rockville, Md., would be embodied by a new company formed to sequence the entire human genome by 2001, and at an estimated cost of $150 million to $300 million. Faster, more automated sequencing machines recently unveiled by Perkin-Elmer, and a different sequencing strategy espoused by Venter make that target feasible. The federally sponsored Human Genome Project, which has a total estimated budget of $3 billion, is on schedule to finish sequencing the approximately 3 billion base pairs of DNA that make up the human genome by 2005.

MIXED SIGNALS: NHGRI's Francis Collins has sent mixed signals about whether the public and private sequencing ventures can cooperate. Francis Collins , director of the National Human Genome Research Institute, cautions ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Paul Smaglik

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide